The Effects of California Strawberries on Parameters of Cardiovascular Health

July 13, 2017 updated by: University of California, Davis
The prevalence of childhood obesity has been increasing over the past couple of decades. Similar to adults, overweight and obesity in young children and adolescents is associated with an increased number of cardiovascular risk factors including dyslipidemia, hypertension, insulin resistance and Type 2 diabetes. Epidemiological and clinical studies suggest that foods and ingredients rich in select flavonoids, such as cocoa, red grape products, tea, citrus fruits, and strawberries are protective against the development of cardiovascular disease. Strawberries are rich in flavonoids, particularly anthocyanins, flavanols, flavonols, ellagic acid and its glucose ester, ellagitanin. A number of in vitro studies have observed that these isolated compounds, as well as strawberry extracts have the potential to affect outcomes of cardiovascular health, including vascular reactivity, cellular signaling and oxidant defense6,7. We hypothesize that strawberry intake will lead to improvements in select measures of cardiovascular function in overweight and obese adolescent males.

Study Overview

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Davis, California, United States, 95616
        • Ragle Human Nutrition Research Center, Academic Surge, UC Davis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male subjects, age 14 - 18 years.
  • BMI for age and gender >75th percentile (based on CDC growth charts)
  • Subject is willing and able to comply with the study protocols.

Exclusion Criteria:

  • Inability to wear PAT probes
  • Inability to remain still and remain quiet during test procedures
  • BMI for age and gender ≤ 75th percentile (based on CDC growth charts)
  • The use of medications that affect vascular function
  • Regular use of dietary supplements during the last 6 months
  • Blood pressure for age, gender and height ≥95th percentile
  • Chronic/routine high intensity exercise or current participation in a sports program
  • Self/Parent reported use of anticoagulation agents including NSAIDs
  • Self/Parent reported use of oral cortisone or other immunosuppressive agents,
  • Self/Parent reported underlying neoplasia or immunological disease
  • Self/Parent reported diabetes
  • Food faddists or those taking a non-traditional diet
  • Allergies to fruit
  • Abnormal Liver, CBC or Chemistry panels (laboratory values outside the reference
  • range) if determined to be clinically significant by the study physician.
  • Self/Parent reported malabsorption (e.g. difficulty digesting or absorbing nutrients from food, potentially leading to bloating, cramping or gas).
  • Asthma (can be worsened by mild to moderate food allergies).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Flavonoid-rich freeze-dried strawberry powder
50g of flavonoid-rich freeze-dried strawberry powder
50g of flavonoid-rich freeze-dried strawberry powder
Placebo Comparator: macronutrient- matched control powder
50g macronutrient-matched control powder that will lack strawberry flavonoids
50g macronutrient-matched powder that will lack strawberry flavonoids

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vascular function measured by peripheral arterial tonometry
Time Frame: Change from baseline in vascular function at 1 hour and 1 week
Change from baseline at 1 hour and 1 week post consumption of freeze-dried strawberry powder or control powder
Change from baseline in vascular function at 1 hour and 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2012

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

August 31, 2012

First Submitted That Met QC Criteria

October 10, 2012

First Posted (Estimate)

October 12, 2012

Study Record Updates

Last Update Posted (Actual)

July 14, 2017

Last Update Submitted That Met QC Criteria

July 13, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on flavonoid-rich freeze-dried strawberry powder

Subscribe